Company Filing History:
Years Active: 2010
Title: Marie-Pierre De Bethune: Innovator in HIV Protease Inhibitors
Introduction
Marie-Pierre De Bethune is a notable inventor based in Everberg, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the development of HIV protease inhibitors. Her innovative work has led to the filing of a patent that addresses critical health challenges.
Latest Patents
Marie-Pierre De Bethune holds a patent for "Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors." This invention concerns compounds that include N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs, esters, and metabolites. The patent outlines their use as broad-spectrum HIV protease inhibitors, detailing processes for their preparation, as well as pharmaceutical compositions and diagnostic kits that incorporate these compounds.
Career Highlights
Throughout her career, Marie-Pierre has been associated with Tibotec Pharmaceuticals Ltd., where she has played a pivotal role in advancing research and development in antiviral therapies. Her work has been instrumental in creating effective treatments for HIV, showcasing her dedication to improving public health.
Collaborations
Marie-Pierre has collaborated with esteemed colleagues, including Dominique Louis Nestor Ghislain Surleraux and Piet Tom Bert Paul Wigerinck. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new therapeutic solutions.
Conclusion
Marie-Pierre De Bethune's contributions to the field of HIV research exemplify her commitment to innovation and public health. Her patent for HIV protease inhibitors represents a significant advancement in the fight against this global health issue.